COULIE BERNARD (President and CEO) sold 10.9% of their position (52.42K shares) of PLIANT THERAPEUTICS, INC. on the open market
Open‑market sale worth $587.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2025ACC: 0001746473-25-000006
DirectorOfficer· President and CEO
Since Jun 2020
-52.42K
Net shares
Net seller
$587.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
52.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−52.42K
Price / share
$11.20
Trade value
$587.15K
% of position
10.9%
1/17/2025
482.94K→430.52K
Total
Net shares
−52.42K
Net value
-$587.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2025 | S · Sale | −52.42K | $11.20 | $587.15K | 10.9% | 482.94K | 430.52K |
| Total | −52.42K | -$587.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned409.32K
Total
409.32K indirect409.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 409.32K | Indirect |
| Total | 409.32K | 409.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported